06:38 AM EDT, 05/13/2025 (MT Newswires) -- The US Centers for Medicare and Medicaid Services said Monday it will outline a list of 15 drugs eligible for a third round of Medicare price negotiations by early February 2026.

The list will include drugs payable under Medicare part B for the first time, in addition to prescription drugs covered under Medicare part D, the agency said.

Negotiated prices from the third round will take effect on Jan. 1, 2028, the CMS said.